awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38977166-8F182675-9689-4B7E-B6B7-C906E9769B04
Q38977166-8F182675-9689-4B7E-B6B7-C906E9769B04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38977166-8F182675-9689-4B7E-B6B7-C906E9769B04
The challenges of pharmacokinetic variability of first-line anti-TB drugs.
P2860
Q38977166-8F182675-9689-4B7E-B6B7-C906E9769B04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38977166-8F182675-9689-4B7E-B6B7-C906E9769B04
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fb32b6b1b80d0d7b9baf3430ab0b97d3dc8c4ce4
P2860
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy